Table 1

England (1999–2011): number of people in the study with each immune-mediated disease, and percentage who were female
Immune-mediated diseases (ICD-10 codes) and reference N Female (%)
Addison’s disease (E27.1) [3] 12,506 60.0
Ankylosing spondylitis (M45) [7] 30,281 30.4
Autoimmune hemolytic anemia (D59.1) [8] 9,696 54.0
Chronic active hepatitis (K73.2) 4,761 70.0
Crohn’s disease (K50) [9] 137,432 55.9
Coeliac disease (K90.0) [4] 70,300 66.5
Dermatomyositis (M33.0 to M33.1) [10] 2,903 67.1
Polymyositis (M33.2) [10] 4,130 62.3
Goodpasture’s syndrome (M31.0) [11] 1,157 49.5
Hashimoto’s thyroiditis (E06.3) 8,571 90.6
Idiopathic thrombocytopenia purpura (D69.3) [12] 31,821 54.7
Multiple sclerosis (G35) [13] 87,930 69.1
Myasthenia gravis (G70.0) [14] 11,745 49.8
Myxedema (E03.8 to E03.9) [15] 941,746 80.6
Pemphigus (L10) 2,341 57.2
Pemphigoid (L12) [16] 13,585 56.1
Pernicious anemia (D51.0) 68,679 68.4
Polyarteritis nodosa (M30.0) [17] 2,419 44.4
Primary biliary cirrhosis (K74.3) [18] 11,617 84.6
Psoriasis (L40) [19] 121,003 48.3
Rheumatoid arthritis (M05 to M06) [5] 346,804 71.1
Scleroderma (M34) [20] 12,681 81.9
Sjögren’s syndrome (M35.0) 18,791 88.6
Systemic lupus erythematosus (M32.1 to M32.9) [6] 27,519 86.7
Thyrotoxicosis (E05) 133,971 78.6
Ulcerative colitis (K51) [21] 191,977 48.7

References indicate some previous studies linking disorder with tuberculosis (TB). ICD-10 = International Classification of Diseases, tenth edition.

Ramagopalan et al.

Ramagopalan et al. BMC Medicine 2013 11:97   doi:10.1186/1741-7015-11-97

Open Data